BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25801813)

  • 21. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E; Kristensson K; Ljunggren HG
    Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
    Zwirner NW; Fuertes MB; Girart MV; Domaica CI; Rossi LE
    Cytokine Growth Factor Rev; 2007; 18(1-2):159-70. PubMed ID: 17324607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
    Bae DS; Hwang YK; Lee JK
    Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in NKG2D ligand recognition and responses by NK cells.
    Le Bert N; Gasser S
    Immunol Cell Biol; 2014 Mar; 92(3):230-6. PubMed ID: 24445601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC.
    Basher F; Jeng EK; Wong H; Wu J
    Oncotarget; 2016 Jan; 7(1):814-30. PubMed ID: 26625316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
    Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
    Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SHIP1 intrinsically regulates NK cell signaling and education, resulting in tolerance of an MHC class I-mismatched bone marrow graft in mice.
    Gumbleton M; Vivier E; Kerr WG
    J Immunol; 2015 Mar; 194(6):2847-54. PubMed ID: 25687756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.
    Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R
    Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer immunotherapy using NKG2D and DNAM-1 systems.
    Morisaki T; Onishi H; Katano M
    Anticancer Res; 2012 Jun; 32(6):2241-7. PubMed ID: 22641658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H; Kim J; Cosman D; Choi I
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.
    Campbell AR; Duggan MC; Suarez-Kelly LP; Bhave N; Opheim KS; McMichael EL; Trikha P; Parihar R; Luedke E; Lewis A; Yung B; Lee R; Raulet D; Tridandapani S; Groh V; Yu L; Yildiz V; Byrd JC; Caligiuri MA; Carson WE
    Cancer Immunol Res; 2017 Sep; 5(9):778-789. PubMed ID: 28724544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-β1 regulates human renal proximal tubular epithelial cell susceptibility to natural killer cells via modulation of the NKG2D ligands.
    Song H; Kim Y; Park G; Kim YS; Kim S; Lee HK; Chung WY; Park SJ; Han SY; Cho D; Hur D
    Int J Mol Med; 2015 Oct; 36(4):1180-8. PubMed ID: 26311146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells.
    Zingoni A; Cecere F; Vulpis E; Fionda C; Molfetta R; Soriani A; Petrucci MT; Ricciardi MR; Fuerst D; Amendola MG; Mytilineos J; Cerboni C; Paolini R; Cippitelli M; Santoni A
    J Immunol; 2015 Jul; 195(2):736-48. PubMed ID: 26071561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
    Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W
    Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [B7-H6 : a novel alert signal for NK cells].
    Baratin M; Vivier E
    Med Sci (Paris); 2010 Feb; 26(2):119-20. PubMed ID: 20188033
    [No Abstract]   [Full Text] [Related]  

  • 37. Cattle MIC is a ligand for the activating NK cell receptor NKG2D.
    Guzman E; Birch JR; Ellis SA
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):227-34. PubMed ID: 20399506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells.
    Nakajima NI; Niimi A; Isono M; Oike T; Sato H; Nakano T; Shibata A
    Oncol Rep; 2017 Aug; 38(2):693-702. PubMed ID: 28677817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.